Patent · US Active

Triterpene saponin derivative and use thereof

US12234257B2 · kind B2 · utility

0Cited by
0References
6Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 12, 2021
Grant dateFeb 25, 2025
Priority date
Expiry dateAug 7, 2042

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P25/28
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided are astersaponin I, which is a novel triterpene saponin derivative isolated and identified from a Aster koraiensis Nakai (Korean starwort) extract, and a use thereof for preventing or treating a neurodegenerative disorder.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.